These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 27648404)
1. Vascular calcification: When should we interfere in chronic kidney disease patients and how? Sharaf El Din UA; Salem MM; Abdulazim DO World J Nephrol; 2016 Sep; 5(5):398-417. PubMed ID: 27648404 [TBL] [Abstract][Full Text] [Related]
2. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model. Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous vascular calcifications in patients with chronic kidney disease and calcific uremic arteriolopathy: a cross-sectional study. Røndbjerg AK; Gyldenløve M; Krustrup D; Rix M; Vejborg I; Lonn L; Jørgensen NR; Pasch A; Skov L; Hansen D J Nephrol; 2023 Sep; 36(7):1991-1999. PubMed ID: 37466817 [TBL] [Abstract][Full Text] [Related]
4. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications. Kaur R; Singh R Life Sci; 2022 Dec; 311(Pt B):121148. PubMed ID: 36336124 [TBL] [Abstract][Full Text] [Related]
5. Uremic serum-induced calcification of human aortic smooth muscle cells is a regulated process involving Klotho and RUNX2. Patidar A; Singh DK; Thakur S; Farrington K; Baydoun AR Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519772 [TBL] [Abstract][Full Text] [Related]
6. Klotho deficiency causes vascular calcification in chronic kidney disease. Hu MC; Shi M; Zhang J; Quiñones H; Griffith C; Kuro-o M; Moe OW J Am Soc Nephrol; 2011 Jan; 22(1):124-36. PubMed ID: 21115613 [TBL] [Abstract][Full Text] [Related]
7. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Lim K; Lu TS; Molostvov G; Lee C; Lam FT; Zehnder D; Hsiao LL Circulation; 2012 May; 125(18):2243-55. PubMed ID: 22492635 [TBL] [Abstract][Full Text] [Related]
8. Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure. Cernaro V; Longhitano E; Calabrese V; Casuscelli C; Di Carlo S; Spinella C; Gembillo G; Santoro D Expert Opin Pharmacother; 2023; 24(15):1737-1746. PubMed ID: 37527180 [TBL] [Abstract][Full Text] [Related]
9. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats. de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365 [TBL] [Abstract][Full Text] [Related]
10. Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease. Rastogi A Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):322-42. PubMed ID: 24327730 [TBL] [Abstract][Full Text] [Related]
11. Phosphate Toxicity and Vascular Calcification in Chronic Kidney Disease: A Closer Look Utilizing Transmission Electron Microscopy. Yang Y; Yang K; Xiong Y; He Y; Zhou Y; Hayden MR Curr Protein Pept Sci; 2023; 24(8):621-639. PubMed ID: 37496135 [TBL] [Abstract][Full Text] [Related]
12. The role of klotho on vascular calcification and endothelial function in chronic kidney disease. Vervloet MG; Adema AY; Larsson TE; Massy ZA Semin Nephrol; 2014 Nov; 34(6):578-85. PubMed ID: 25498377 [TBL] [Abstract][Full Text] [Related]
13. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. Yamada S; Taniguchi M; Tokumoto M; Toyonaga J; Fujisaki K; Suehiro T; Noguchi H; Iida M; Tsuruya K; Kitazono T J Bone Miner Res; 2012 Feb; 27(2):474-85. PubMed ID: 21987400 [TBL] [Abstract][Full Text] [Related]
14. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification. Liu L; Liu Y; Zhang Y; Bi X; Nie L; Liu C; Xiong J; He T; Xu X; Yu Y; Yang K; Gu J; Huang Y; Zhang J; Zhang Z; Zhang B; Zhao J J Mol Cell Cardiol; 2018 Jan; 114():264-275. PubMed ID: 29197521 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiological mechanisms and consequences of cardiovascular calcifications: role of uremic toxicity. Chillon JM; Mozar A; Six I; Maizel J; Bugnicourt JM; Kamel S; Slama M; Brazier M; Massy ZA Ann Pharm Fr; 2009 Jul; 67(4):234-40. PubMed ID: 19596096 [TBL] [Abstract][Full Text] [Related]
16. Coronary artery calcification and cardiovascular disease in children with chronic kidney disease. Paoli S; Mitsnefes MM Curr Opin Pediatr; 2014 Apr; 26(2):193-7. PubMed ID: 24632542 [TBL] [Abstract][Full Text] [Related]
18. [Klotho and vascular calcification]. Matsui M; Saito Y Clin Calcium; 2016 Aug; 26(8):1157-64. PubMed ID: 27461499 [TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960 [TBL] [Abstract][Full Text] [Related]
20. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. Hu MC; Shi M; Cho HJ; Adams-Huet B; Paek J; Hill K; Shelton J; Amaral AP; Faul C; Taniguchi M; Wolf M; Brand M; Takahashi M; Kuro-O M; Hill JA; Moe OW J Am Soc Nephrol; 2015 Jun; 26(6):1290-302. PubMed ID: 25326585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]